A Cyclopropane-Derived Stable Analog Of Fd-895 Induces Apoptosis and Inhibition Of mRNA Splicing In Lymphoma and Chronic Lymphocytic Leukemia: A Novel Therapeutic Approach
Deepak Kumar, Manoj Kumar Kashyap, Ide Spaanderman et al.




Key Points:
  • RNA splicing implicated in tumorigenesis.

  • Spliceosome inhibitors (FD-895 and Pladienolide B (PLAD-B)) with improved biochemical stability potent pro-apoptotic activity in CLL.

  • Intron retention and development of apoptosis.

  • Expression of alternative spliced pro-apoptotic forms.

Implications:

  • Spliceosome inhibitors can be used for cancer treatment.

View the original abstract on the ASH website.






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements